Skip to main content
Fig. 16 | Journal of Nanobiotechnology

Fig. 16

From: Role of bioactive magnetic nanoparticles in the prevention of wound pathogenic biofilm formation using smart nanocomposites

Fig. 16

MTT assay results of the a IONPs-free nanocomposites containing 0, 0.05, 0.5, and 1% AgNPs; b AgNPs-free nanocomposites containing 0, 5, 10, and 15% IONPs; c Ag/IO nanocomposites containing 0.05, 0.5, and 1% AgNPs; and 5, 10, and 15% IONPs on days 1, 3, 5 and 7; d Ag/IO nanocomposites containing 0.05, 0.5, and 1% AgNPs; and 5, 10, and 15% IONPs on the 7th day in the absence and presence of EMF. Data are reported as mean ± SD (n = 5 and *p < 0.05)

Back to article page